The study revealed that the concurrent administration of Korean red ginseng alongside adjuvant chemotherapy led to an increased count of CD4+ lymphocytes and a higher CD4+/CD8+ T lymphocyte ratio following chemotherapy in individuals diagnosed with bile duct or pancreatic cancer. This evidence concerns the gene CD4 and pancreatic neoplasm.